This chapter provides information on viral zoonotic infections in humans, transmitted from animals, caused by rabiesvirus, influenzaviruses, HEV, poxviruses, hantavirus, Lassa fever virus, ebola, SARS-CoV, MERS-CoV, SARS-CoV-2, nipahvirus, zikavirus. It details which animal hosts are associated with which viruses, modes of spread and strategies for control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to poxviruses (smallpox, monkeypox, cowpox, molluscum contagiosum). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides details of the viruses associated with maculopapular, vesicular and haemorrhagic skin rashes (parvovirus, rubellavirus, measlesvirus, enteroviruses, adenoviruses, HHV6, HHV7 , HSV, VZV, poxviruses , monkeypox and molluscum contagiosum). It gives details of symptoms, diagnosis and treatment.

This chapter provides an overview of the antiviral drugs currently available, including maraviroc, aciclovir, penciclovir, ganciclovir, amantadine, zydovudine, adefovir, ribavirin, indinavir , oseltamivir, zanamivir, interferon alpha, rituximab , palivizumab, cidofovir, brincidofovir, foscarnet, remdesivir and paxlovid with an indication of their modes of action for treating virus infections, including HIV, herpes viruses, respiratory viruses, HBV, HCV, CMV, adenoviruses , BK, EBV (especially for PTLD), RSV, poxviruses and SARS-CoV-2.

This chapter details to genital tract and sexually transmitted infections (HSV, VZV, Treponema pallidum, papillomaviruses, poxviruses, HIV, HBV, C. trachomatis, LGV). It gives information on symptoms, laboratory diagnosis, management, treatment, prophylaxis and infection control.